Policy Plenary: State Policy Approaches to Addiction Medicine Access and Quality (1.5 CME)

(1.5 CME) In this conference recording from the 2018 Annual Conference, you will learn that while the federal government has taken some steps to improve access to and the quality of addiction treatment in recent years, many states also have been busy passing a flurry of laws and writing regulations related to addiction prevention, treatment, and recovery. States hit hard by the opioid overdose epidemic have established Task Forces, declared states of emergency, applied for federal waivers to transform their Medicaid programs, issued naloxone standing orders, and established countless other policies to reduce opioid prescriptions, promote harm reduction strategies, fund treatment, or regulate addiction treatment services. Each state has taken a different approach, but some trends have emerged, allowing for a comparative analysis of policies’ effectiveness and predictions for what policy changes clinicians can expect at home. 

This Policy Plenary will:

  1. Feature state policy experts and officials who will discuss state-level strategies to improve addiction medicine quality and access;
  2. Highlight examples of policies that have worked well and those that have had unintended consequences, and 
  3. Help equip attendees to be effective advocates for good addiction policies in their states.

Jay C. Butler

MD, FAAP, MACP, FIDSA

Jay C. Butler, MD, CPE, FAAP, MACP, FIDSA was appointed Chief Medical Officer for the Alaska Department of Health and Social Services and Director of the Division of Public Health by Governor Bill Walker in December 2014. He is a graduate of the University of North Carolina Medical School, has completed numerous post-doctoral clinical trainings at Vanderbilt and Emory Universities, and maintains board certifications in infectious diseases, internal medical, and pediatrics. He has authored or co-authored over 100 scientific papers and medical textbook chapters on infectious diseases, vaccines, public health and emergency preparedness. He is an affiliate professor of medicine at the University of Alaska Anchorage. 

From 2010 to 2014, Dr. Butler was Senior Director for Community Health Services at the Alaska Native Tribal Health Consortium in Anchorage, where he was also a clinical infectious diseases consultant and Medical Director for Infection Control and Employee Health. Earlier work includes serving as Chief Medical Officer of the Alaska Department of Health Social Services from 2007 to 2009, Alaska State Epidemiologist, 2005-07, Director of the Centers for Disease Control and Prevention’s (CDC) Arctic Investigations Program, 1998-2005, medical epidemiologist in CDC’s National Center for Infectious Diseases in Atlanta, 1991-98, and CDC Epidemic Intelligence Service Officer assigned to the Wisconsin Division of Public Health, 1989-91. 

He completed over 23 years of service as a U.S. Public Health Service medical officer. He served as Governor of the Alaska Chapter of the American College of Physicians from 2005 to 2009 and was the 2017 President of the Association of State and Territorial Health Officials. He is a founding member of the new Alaska Chapter of the American Society of Addiction Medicine.

Daniel Blaney-Koen

JD, MFA

Daniel Blaney-Koen, JD, is a senior legislative attorney with the American Medical Association Advocacy Resource Center (ARC). The ARC attorneys focus on working with state and specialty medical societies on state legislative, regulatory and policy advocacy. In addition to his work in the ARC, Daniel has held several roles at the AMA, including serving as a public information officer, policy analyst and speechwriter. Currently, Daniel focuses on state legislation and policy concerning the nation’s opioid epidemic, with particular emphasis on overdose prevention and treatment. Daniel also covers other pharmaceutical issues, insurance market reforms and other issues. Prior to joining the AMA in 1999, Daniel earned his Master of Fine Arts in Poetry from Colorado State University, and his Bachelor's Degree from the University of Arizona. He earned his law degree from the Loyola University Chicago School of Law. Daniel, his wife, two young sons and daughter live in Chicago, Illinois.

Paul H. Earley

MD, DFASAM

Dr. Earley has worked in Addiction Medicine for over 30 years. He treats all types of addictive disorders and specializes in the assessment, treatment and management of health care professionals. As a therapist, he works with patients already in recovery, providing long term therapy for those who suffer from this disease. His professional expertise extends to advocacy for professionals before agencies and licensing boards. 

Dr. Earley is a dynamic speaker and educator; he speaks and trains on topics of addiction, its treatment and addiction among health care professionals. In addition, he trains therapists about the neurobiological basis of psychotherapy. In his travels, he has provided training in the United States, Canada, the United Kingdom, Italy, Iceland and Switzerland.

He is the author of two books and several research articles on addiction and its treatment. His most recent book, RecoveryMind Training is an innovative and comprehensive process designed to reengineer addiction treatment. He is a contributing author to the American Society of Addiction Medicine (ASAM) Textbook: Principles of Addiction Medicine, as author of the chapter: Physician Health Programs and Addiction among Physicians. He is a contributing author to the ASAM Criteria. His work was featured in the documentary series on addiction entitled Close to Home by Bill Moyers.

Currently, Dr. Earley is the Medical Director of the Georgia Professionals Health Program, Inc., the Physicians Health Program (PHP) for the state of Georgia and the President-elect of the Federation of State Physician Health Programs (FSPHP). Dr. Earley is the current president-elect of the American Society of Addiction Medicine (ASAM). He is a Distinguished Fellow of ASAM and has served on the board of ASAM for over 14 years in several capacities.

Alexandra Duncan

DrPH, MPH

Alexandra Duncan is a senior officer with Pew's substance use prevention and treatment initiative, which works on federal and state initiatives to reduce the inappropriate use of prescription opioids and increase access to evidence-based treatment for substance use disorders. Before joining Pew, Duncan was a research associate at IMPAQ International LLC, where she supported the Center for Consumer Information and Insurance Oversight on issues related to Affordable Care Act compliance with prescription drug and nondiscrimination regulations for high-cost medical conditions, including opioid use disorder, as well as evaluation of health programs. 

Previously, she was a senior analyst for Abt Associates, working in the division of U.S. health, public health, and epidemiology practice on several projects related to HIV testing and the integration of HIV treatment and substance abuse treatment. Duncan completed postdoctoral training in drug dependence epidemiology at John Hopkins University’s Bloomberg School of Public Health after earning a doctor of public health degree from Columbia University. She also holds a master’s degree in public health from Tulane University and a bachelor’s degree from Bryn Mawr College.

ACCME Accredited with Commendation

ACCME Accreditation Statement

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Society of Addiction Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABPM Maintenance of Certification (MOC)

The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1.5 LLSA credits towards ABPM MOC Part II requirements.

ABAM Transitional Maintenance of Certification (tMOC)

This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Transitional Maintenance of Certification Program (tMOC) can apply a maximum of 1.5 AMA PRA Category 1 Credit(s)™ for completing this course.

Key:

Complete
Failed
Available
Locked
Session Recording
Open to view video.
Open to view video. Watch the session recording.
CME Quiz
3 Questions
3 Questions Quiz contains 3 questions and requires 2 correct answers to pass.
CME Evaluation
15 Questions
CME Credit and Certificate
Up to 1.50 medical credits available  |  Certificate available
Up to 1.50 medical credits available  |  Certificate available 1.5 AMA PRA Category 1 Credit(s)™